M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 8 EUR -1.48% Market Closed
Market Cap: 111.4m EUR

Maat Pharma SA
Investor Relations

Maat Pharma SA operates as a clinical-stage microbiome therapeutics company. The company is headquartered in Lyon, Auvergne-Rhone-Alpes and currently employs 43 full-time employees. The company went IPO on 2021-11-08. The firm specializes in the microbiome therapy that is aimed to treatment of Gut Microbiota alteration (Dysbiosis) using patient-specific biotherapeutics in patients with serious medical conditions. Its MaaT Microbiome Restoration Therapy (MMRB) discovery and analysis platform supports the evaluation of drug candidates, the determination of new disease targets and the identification of biomarkers for microbiome-related conditions.

Show more
Loading

Earnings Calls

No Earnings Calls Available

Management

Mr. Herve Affagard
CEO, Co-Founder & Director
No Bio Available
Dr. Joel Dore Ph.D.
Co-Founder & Member of Scientific Advisory Board
No Bio Available
Mr. Pierre Rimbaud
Co-Founder
No Bio Available
Ms. Sian Crouzet
CFO & Financial Director
No Bio Available
Ms. Carole Schwintner
Technology Director & Chief Technology Officer
No Bio Available
Dr. Nathalie Corvaia Ph.D.
Chief Scientific Officer
No Bio Available
Guilhaume Debroas Ph.D.
Head of Investor Relations
No Bio Available
Dr. Emilie Plantamura
Head of Clinical Development
No Bio Available
Mr. Jonathan Chriqui Pharm.D.
Chief Business Officer
No Bio Available
Dr. Gianfranco Pittari M.D., Ph.D.
Chief Medical Officer
No Bio Available

Contacts

Address
AUVERGNE-RHONE-ALPES
Lyon
70 Avenue Tony Garnier
Contacts